Qinyu Han

ORCID: 0000-0003-3464-8967
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myeloid Leukemia Research
  • Protein Degradation and Inhibitors
  • Genomics and Chromatin Dynamics
  • Histone Deacetylase Inhibitors Research
  • CRISPR and Genetic Engineering
  • Chronic Myeloid Leukemia Treatments
  • RNA Research and Splicing
  • Estrogen and related hormone effects
  • Immune Cell Function and Interaction
  • Cancer-related gene regulation
  • Ubiquitin and proteasome pathways
  • Wnt/β-catenin signaling in development and cancer
  • Immunotherapy and Immune Responses
  • Cancer-related Molecular Pathways
  • Hippo pathway signaling and YAP/TAZ
  • Cancer, Lipids, and Metabolism
  • T-cell and B-cell Immunology
  • Caveolin-1 and cellular processes
  • Metabolism, Diabetes, and Cancer

Shandong First Medical University
2023-2024

Affiliated Hospital of Taishan Medical University
2023-2024

California Institute of Technology
2022-2023

<div>Abstract<p>Nucleophosmin (NPM1) is a ubiquitously expressed nucleolar protein with wide range of biological functions. In 30% acute myeloid leukemia (AML), the terminal exon <i>NPM1</i> often found mutated, resulting in addition nuclear export signal and shift to cytoplasm (NPM1c). AMLs carrying this mutation have aberrant expression <i>HOXA/B</i> genes, whose overexpression leads leukemogenic transformation. Here, for first time, we comprehensively...

10.1158/2159-8290.c.6549829.v1 preprint EN 2023-04-04

<div>Abstract<p>Nucleophosmin (NPM1) is a ubiquitously expressed nucleolar protein with wide range of biological functions. In 30% acute myeloid leukemia (AML), the terminal exon <i>NPM1</i> often found mutated, resulting in addition nuclear export signal and shift to cytoplasm (NPM1c). AMLs carrying this mutation have aberrant expression <i>HOXA/B</i> genes, whose overexpression leads leukemogenic transformation. Here, for first time, we comprehensively...

10.1158/2159-8290.c.6549829 preprint EN 2023-04-04

<p>Supplementary Figure S1 is associated with Figure1 and it shows the NPM1-WT binds to rDNA arrays NPM1c non-repetitive genomic regions. Supplementary S2 NPM1c’s chromatin binding association gene expression. S3 Figure2 regulates transcription of its target genes BRU-seq. S4 characterization condensate biochemical assay imaging assay. S5 figure 3. The landacpe dymanics during dTag-13 treatment wash-off. S6 4. It supplemental data HOXB8-NPM1c-knock-in model. S7 5. XPO1's in various...

10.1158/2159-8290.22542214 preprint EN cc-by 2023-04-04

<p>Supplementary Figure S1 is associated with Figure1 and it shows the NPM1-WT binds to rDNA arrays NPM1c non-repetitive genomic regions. Supplementary S2 NPM1c’s chromatin binding association gene expression. S3 Figure2 regulates transcription of its target genes BRU-seq. S4 characterization condensate biochemical assay imaging assay. S5 figure 3. The landacpe dymanics during dTag-13 treatment wash-off. S6 4. It supplemental data HOXB8-NPM1c-knock-in model. S7 5. XPO1's in various...

10.1158/2159-8290.22542214.v1 preprint EN cc-by 2023-04-04

Summary Transcription factors (TFs) activate enhancers to drive cell-specific gene programs in response signals, but our understanding of enhancer assembly during signaling events is incomplete. Here, we show that Androgen Receptor (AR), a steroid hormone-regulated transcription factor, forms condensates through multivalent interactions androgen orchestrate assembly. We demonstrate the intrinsically disordered N-terminal domain (NTD) AR drives 1,6-Hexanediol-sensitive condensate formation...

10.1101/2022.10.28.514297 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2022-10-30

Abstract Nucleophosmin (NPM1) is a ubiquitously expressed nucleolar protein with wide range of functions including ribosome biogenesis, mRNA processing, and maintenance genomic stability. In acute myeloid leukemia (AML), the terminal exon NPM1 often mutated (~30% adult AMLs), changing localization signal into nuclear export signal, which results in shift to cytoplasm (NPM1c). AMLs carrying this mutation have an aberrant expression HOXA genes, whose overexpression leads leukemogenic...

10.1158/1538-7445.cancepi22-pr001 article EN Cancer Research 2022-12-01
Coming Soon ...